A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma

Trial Profile

A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Dec 2016

At a glance

  • Drugs RG 6149 (Primary) ; RG 6149 (Primary)
  • Indications Asthma
  • Focus Adverse reactions; First in man; Pharmacodynamics
  • Sponsors Amgen
  • Most Recent Events

    • 13 Dec 2016 Status changed from active, no longer recruiting to completed.
    • 04 May 2016 Planned End Date changed from 1 Apr 2016 to 1 Jun 2016.
    • 04 May 2016 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top